Literature DB >> 25906969

Investigation of travel-related cases in a multinational outbreak: example of the Shiga-toxin producing E. coli outbreak in Germany, May-June 2011.

I Devaux1, C Varela-Santos1, L Payne-Hallström1, J Takkinen1, C Bogaardt1, D Coulombier1.   

Abstract

Early investigation of travel-related cases in an outbreak of an emerging infectious disease can provide useful information to epidemiologists to characterize the exposure, while they may differ in demographic profiles from cases reported in the country where the outbreak has occurred. During the spring 2011 E. coli outbreak in Germany, we proposed a methodological approach to collect a minimal set of demographic and clinical data that are relatively easy to obtain and available at an early stage of an outbreak investigation. Ninety-eight STEC O104 travel-related cases were reported in a survey by seven EU countries, Switzerland, Canada and the USA. We found a mean incubation period (n = 50) of 8·5 days, which confirmed previous estimations communicated by the Robert Koch Institute. No significant association was found between the duration of the incubation period and possible demographic and clinical factors, although the older the age, the shorter the incubation period that was observed. Such approach and observations are informative for further investigations of outbreaks of enterohaemorrhagic E. coli or other emerging infectious diseases.

Entities:  

Keywords:  Escherichia coli (E. coli); investigation; outbreaks; travellers' infection

Mesh:

Year:  2015        PMID: 25906969      PMCID: PMC9150957          DOI: 10.1017/S0950268814003823

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  9 in total

1.  Enhanced surveillance during a large outbreak of bloody diarrhoea and haemolytic uraemic syndrome caused by Shiga toxin/verotoxin-producing Escherichia coli in Germany, May to June 2011.

Authors:  M Wadl; T Rieck; M Nachtnebel; B Greutélaers; M an der Heiden; D Altmann; W Hellenbrand; M Faber; C Frank; B Schweickert; G Krause; J Benzler; T Eckmanns
Journal:  Euro Surveill       Date:  2011-06-16

2.  Large and ongoing outbreak of haemolytic uraemic syndrome, Germany, May 2011.

Authors:  C Frank; M S Faber; M Askar; H Bernard; A Fruth; A Gilsdorf; M Hohle; H Karch; G Krause; R Prager; A Spode; K Stark; D Werber
Journal:  Euro Surveill       Date:  2011-05-26

3.  Update on the ongoing outbreak of haemolytic uraemic syndrome due to Shiga toxin-producing Escherichia coli (STEC) serotype O104, Germany, May 2011.

Authors:  M Askar; M S Faber; C Frank; H Bernard; A Gilsdorf; A Fruth; R Prager; M Hohle; T Suess; M Wadl; G Krause; K Stark; D Werber
Journal:  Euro Surveill       Date:  2011-06-02

4.  The epidemiologic field investigation: science and judgment in public health practice.

Authors:  R A Goodman; J W Buehler; J P Koplan
Journal:  Am J Epidemiol       Date:  1990-07       Impact factor: 4.897

5.  Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.

Authors:  Christina Frank; Dirk Werber; Jakob P Cramer; Mona Askar; Mirko Faber; Matthias an der Heiden; Helen Bernard; Angelika Fruth; Rita Prager; Anke Spode; Maria Wadl; Alexander Zoufaly; Sabine Jordan; Markus J Kemper; Per Follin; Luise Müller; Lisa A King; Bettina Rosner; Udo Buchholz; Klaus Stark; Gérard Krause
Journal:  N Engl J Med       Date:  2011-06-22       Impact factor: 91.245

6.  German outbreak of Escherichia coli O104:H4 associated with sprouts.

Authors:  Udo Buchholz; Helen Bernard; Dirk Werber; Merle M Böhmer; Cornelius Remschmidt; Hendrik Wilking; Yvonne Deleré; Matthias an der Heiden; Cornelia Adlhoch; Johannes Dreesman; Joachim Ehlers; Steen Ethelberg; Mirko Faber; Christina Frank; Gerd Fricke; Matthias Greiner; Michael Höhle; Sofie Ivarsson; Uwe Jark; Markus Kirchner; Judith Koch; Gérard Krause; Petra Luber; Bettina Rosner; Klaus Stark; Michael Kühne
Journal:  N Engl J Med       Date:  2011-10-26       Impact factor: 91.245

7.  Associations of age and sex with the clinical outcome and incubation period of Shiga toxin-producing Escherichia coli O104:H4 infections, 2011.

Authors:  Dirk Werber; Lisa A King; Luise Müller; Per Follin; Udo Buchholz; Helen Bernard; Bettina Rosner; Steen Ethelberg; Henriette de Valk; Michael Höhle
Journal:  Am J Epidemiol       Date:  2013-08-08       Impact factor: 4.897

8.  Timeliness of surveillance during outbreak of Shiga Toxin-producing Escherichia coli infection, Germany, 2011.

Authors:  Mathias Altmann; Anke Spode; Doris Altmann; Maria Wadl; Justus Benzler; Tim Eckmanns; Gerard Krause; Matthias An der Heiden
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

9.  Analysis of timeliness of infectious disease reporting in the Netherlands.

Authors:  Elisabeth Reijn; Corien M Swaan; Mirjam E E Kretzschmar; Jim E van Steenbergen
Journal:  BMC Public Health       Date:  2011-05-30       Impact factor: 3.295

  9 in total
  1 in total

1.  Incubation Period of Shiga Toxin-Producing Escherichia coli.

Authors:  Adedoyin Awofisayo-Okuyelu; Julii Brainard; Ian Hall; Noel McCarthy
Journal:  Epidemiol Rev       Date:  2019-01-31       Impact factor: 6.222

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.